公开(公告)号：US12077498B2

公开(公告)日：2024-09-03

申请号：US18218216

申请日：2023-07-05

Applicant: Enveric Biosciences Canada Inc.

Inventor： Jillian M. Hagel ,  Ye Cai ,  Kaveh Matinkhoo ,  David James Press ,  Glynnis Elizabeth Jensen ,  Peter J. Facchini

IPC: C07D209/16 ,  A61K31/4045 ,  A61P25/00 ,  C07D209/20 ,  C07D401/12 ,  C07D403/12 ,  C07D405/12

CPC classification number: C07D209/16 ,  A61K31/4045 ,  A61P25/00 ,  C07D209/20 ,  C07D401/12 ,  C07D403/12 ,  C07D405/12

Abstract: Disclosed are novel C4-carboxylic acid-substituted tryptamine derivative compounds and pharmaceutical and recreational drug formulations containing the same. The pharmaceutical formulations may be used to treat brain neurological disorders.

公开(公告)号：US20240199568A1

公开(公告)日：2024-06-20

申请号：US18512910

申请日：2023-11-17

Applicant: Enveric Biosciences Canada Inc.

Inventor： Kaveh Matinkhoo ,  David James Press ,  Glynnis Elizabeth Jensen ,  Charlie Cai ,  Jillian M. Hagel ,  Peter J. Facchini

IPC: C07D317/58 ,  C07D405/06

CPC classification number: C07D317/58 ,  C07D405/06

Abstract: Disclosed are novel fused mescaline derivative compounds, notably substituted N-propylamine fused heterocyclic mescaline derivatives, including substituted N-propylamine fused dioxolane mescaline derivatives, and pharmaceutical and recreational drug formulations containing the same. Methods of making and using these compounds are also disclosed.

公开(公告)号：US11945778B2

公开(公告)日：2024-04-02

申请号：US18203823

申请日：2023-05-31

Applicant: Enveric Biosciences Canada Inc.

Inventor： Jillian M. Hagel ,  Kaveh Matinkhoo ,  Peter J. Facchini

IPC: A61K31/4045 ,  A61P25/00 ,  C07D209/16 ,  C07D209/20 ,  C07D401/12 ,  C07D403/12 ,  C07D405/12

CPC classification number: C07D209/16 ,  A61K31/4045 ,  A61P25/00 ,  C07D209/20 ,  C07D401/12 ,  C07D403/12 ,  C07D405/12

Abstract: Disclosed are novel C4-carbonothioate-substituted tryptamine derivative compounds and pharmaceutical and recreational drug formulations containing the same. The pharmaceutical formulations may be used to treat brain neurological disorders.

公开(公告)号：US20230295084A1

公开(公告)日：2023-09-21

申请号：US17885978

申请日：2022-08-11

Applicant: Enveric Biosciences Canada Inc.

Inventor： Jillian M. Hagel ,  Ye Cai ,  Kaveh Matinkhoo ,  David James Press ,  Glynnis Elizabeth Jensen ,  Peter J. Facchini

IPC: C07D209/16

CPC classification number: C07D209/16

Abstract: Disclosed are novel C4-carboxylic acid-substituted tryptamine derivative compounds and pharmaceutical and recreational drug formulations containing the same. The pharmaceutical formulations may be used to treat brain neurological disorders.

公开(公告)号：US20240246924A1

公开(公告)日：2024-07-25

申请号：US18541304

申请日：2023-12-15

Applicant: Enveric Biosciences Canada Inc.

Inventor： Kaveh Matinkhoo ,  David James Press ,  Jessica Lee ,  Charlie Cai ,  Jillian M. Hagel ,  Peter J. Facchini

IPC: C07D317/60 ,  C07D317/58 ,  C07D317/64 ,  C07D405/06 ,  C07D413/06

CPC classification number: C07D317/60 ,  C07D317/58 ,  C07D317/64 ,  C07D405/06 ,  C07D413/06

Abstract: Disclosed are novel fused mescaline derivative compounds, notably substituted ethylamine fused heterocyclic mescaline derivatives, including substituted ethylamine fused dioxolane mescaline derivatives, and pharmaceutical and recreational drug formulations containing the same. Methods of making and using these compounds are also disclosed.

公开(公告)号：US20230357185A1

公开(公告)日：2023-11-09

申请号：US17886075

申请日：2022-08-11

Applicant: Enveric Biosciences Canada Inc.

Inventor： Jillian M. Hagel ,  Ye Cai ,  Kaveh Matinkhoo ,  David James Press ,  Glynnis Elizabeth Jensen ,  Peter J. Facchini

IPC: C07D209/16 ,  C07D403/12 ,  C07D401/12 ,  C07D405/12

CPC classification number: C07D401/12 ,  C07D209/16 ,  C07D403/12 ,  C07D405/12

Abstract: Disclosed are novel C4-carboxylic acid-substituted tryptamine derivative compounds and pharmaceutical and recreational drug formulations containing the same. The pharmaceutical formulations may be used to treat brain neurological disorders.

公开(公告)号：US20230321040A1

公开(公告)日：2023-10-12

申请号：US18203823

申请日：2023-05-31

Applicant: Enveric Biosciences Canada Inc.

Inventor： Jillian M. Hagel ,  Kaveh Matinkhoo ,  Peter J. Facchini

IPC: A61K31/4045 ,  C07D209/20 ,  A61P25/00

CPC classification number: A61K31/4045 ,  C07D209/16 ,  A61P25/00 ,  C07D209/20

Abstract: Disclosed are novel C4-carbonothioate-substituted tryptamine derivative compounds and pharmaceutical and recreational drug formulations containing the same. The pharmaceutical formulations may be used to treat brain neurological disorders.

公开(公告)号：US20250129036A1

公开(公告)日：2025-04-24

申请号：US18982705

申请日：2024-12-16

Applicant: Enveric Biosciences Canada Inc.

Inventor： Kaveh Matinkhoo ,  David James Press ,  Glynnis Elizabeth Jensen ,  Jillian M. Hagel ,  Peter J. Facchini

IPC: C07D317/58 ,  A61P25/00 ,  C07D319/18 ,  C07D405/06

Abstract: Disclosed are novel fused mescaline derivative compounds, notably C1-substituted isopropylamine fused heterocyclic mescaline derivatives, including C1-substituted isopropylamine fused dioxolane and fused dioxane mescaline derivatives, and pharmaceutical and recreational drug formulations containing the same. Methods of making and using these compounds are also disclosed.

公开(公告)号：US12065404B2

公开(公告)日：2024-08-20

申请号：US17886075

申请日：2022-08-11

Applicant: Enveric Biosciences Canada Inc.

Inventor： Jillian M. Hagel ,  Ye Cai ,  Kaveh Matinkhoo ,  David James Press ,  Glynnis Elizabeth Jensen ,  Peter J. Facchini

IPC: C07D209/16 ,  A61K31/4045 ,  A61P25/00 ,  C07D209/20 ,  C07D401/12 ,  C07D403/12 ,  C07D405/12

CPC classification number: C07D209/16 ,  A61K31/4045 ,  A61P25/00 ,  C07D209/20 ,  C07D401/12 ,  C07D403/12 ,  C07D405/12

Abstract: Disclosed are novel C4-carboxylic acid-substituted tryptamine derivative compounds and pharmaceutical and recreational drug formulations containing the same. The pharmaceutical formulations may be used to treat brain neurological disorders.

公开(公告)号：US20240116907A1

公开(公告)日：2024-04-11

申请号：US18230332

申请日：2023-08-04

Applicant: Enveric Biosciences Canada Inc.

Inventor： Peter J. Facchini ,  Jillian M. Hagel ,  Chang-Chun Ling ,  Charlie Cai ,  David James Press ,  Glynnis Elizabeth Jensen ,  Jessica Bik-Jing Lee ,  Kaveh Matinkhoo

IPC: C07D407/12 ,  C07D317/58 ,  C07D405/06 ,  C07D405/12

CPC classification number: C07D407/12 ,  C07D317/58 ,  C07D405/06 ,  C07D405/12

Abstract: Disclosed are novel fused heterocyclic mescaline derivative compounds, notably fused heterocyclic mescaline derivatives and pharmaceutical and recreational drug formulations containing the same. Methods of making and using these compounds are also disclosed.